EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
28 hedge funds and large institutions have $25M invested in Eagle Pharmaceuticals, Inc. in 2014 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
28
Holders Change
–
Holders Change %
0%
% of All Funds
0.81%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
5
Reduced
6
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
![]()
JPMorgan Chase & Co
New York
|
-$2.27M |
2 |
Jennison Associates
New York
|
-$1.13M |
3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$1M |
4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$364K |
5 |
Morgan Stanley
New York
|
-$328K |